Skip to main content

Olmesartan Medoxomil

NDC 46708-133 · Alembic Pharmaceuticals Limited

Generic nameOlmesartan Medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL
Strength40 mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
Marketing categoryANDA

Packages

46708-133-10 — 100 TABLET, FILM COATED in 1 CARTON (46708-133-10)

46708-133-30 — 30 TABLET, FILM COATED in 1 BOTTLE (46708-133-30)

46708-133-90 — 90 TABLET, FILM COATED in 1 BOTTLE (46708-133-90)

46708-133-91 — 1000 TABLET, FILM COATED in 1 BOTTLE (46708-133-91)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

42571-248 — Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide, 42571-249 — Olmesartan Medoxomil, Amlodipine besylate and Hydrochlorothiazide, 43547-299 — olmesartan medoxomil, 43547-300 — olmesartan medoxomil, 43547-301 — olmesartan medoxomil, 43547-391 — olmesartan medoxomil and hydrochlorothiazide, 43547-392 — olmesartan medoxomil and hydrochlorothiazide, 43547-393 — olmesartan medoxomil and hydrochlorothiazide, 46708-131 — Olmesartan Medoxomil, 46708-132 — Olmesartan Medoxomil, 46708-149 — Olmesartan Medoxomil and Hydrochlorothiazide, 46708-150 — Olmesartan Medoxomil and Hydrochlorothiazide, 46708-151 — Olmesartan Medoxomil and Hydrochlorothiazide, 46708-212 — Amlodipine besylate and Olmesartran medoxomil, 46708-213 — Amlodipine besylate and Olmesartran medoxomil, 46708-214 — Amlodipine besylate and Olmesartran medoxomil, 46708-215 — Amlodipine besylate and Olmesartran medoxomil, 49252-065 — olmesartan medoxomil, 49252-066 — olmesartan medoxomil, 49252-067 — OLMESARTAN MEDOXOMIL, +281 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels